(S (S (NP (NN Knee) (NN osteoarthritis) (PRN (-LRB- -LRB-) (NP (NN OA)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT the) (ADJP (RBS most) (JJ common)) (NML (JJ musculoskeletal) (NN disease))) (PP (IN without) (NP (DT a) (NN cure))))) (, ,) (CC and) (S (NP (JJ current) (NN treatment) (NNS options)) (VP (VBP are) (VP (VBN limited) (PP (IN to) (NP (JJ symptomatic) (NN relief)))))) (. .))
(S (S (NP (NP (NN Prediction)) (PP (IN of) (NP (NN OA) (NN progression)))) (VP (VBZ is) (NP (DT a) (ADJP (RB very) (JJ challenging) (CC and) (JJ timely)) (NN issue)))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD could) (, ,) (SBAR (IN if) (S (VP (VBN resolved)))) (, ,) (VP (VP (VB accelerate) (NP (DT the) (ADJP (NN disease) (VBG modifying)) (NN drug) (NN development))) (CC and) (ADVP (RB ultimately)) (VP (VB help) (S (VP (TO to) (VP (VB prevent) (NP (NP (NNS millions)) (PP (IN of) (NP (NP (JJ total) (JJ joint) (NN replacement) (NNS surgeries)) (VP (VBN performed) (ADVP (RB annually))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (ADJP (NP (JJ multi-modal) (NN machine) (NN learning)) (HYPH -) (VBN based)) (NNP OA) (NN progression) (NN prediction) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ utilizes) (NP (NP (JJ raw) (JJ radiographic) (NNS data)) (, ,) (NP (JJ clinical) (NN examination) (NNS results)) (CC and) (NP (NP (JJ previous) (JJ medical) (NN history)) (PP (IN of) (NP (DT the) (NN patient)))))))))) (. .))
(S (NP (PRP We)) (VP (VBD validated) (NP (DT this) (NN approach)) (PP (IN on) (NP (NP (DT an) (JJ independent) (NN test) (NN set)) (PP (IN of) (NP (CD 3,918) (NN knee) (NNS images))))) (PP (IN from) (NP (CD 2,129) (NNS subjects)))) (. .))
(S (NP (PRP$ Our) (NN method)) (VP (VBD yielded) (NP (NP (NP (NN area)) (PP (IN under) (NP (NP (NP (DT the) (NNP ROC) (NN curve)) (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-)) (PP (IN of) (NP (CD 0.79))) (PRN (-LRB- -LRB-) (NP (CD 0.78) (SYM -) (CD 0.81)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (JJ Average) (NNP Precision)) (-LRB- -LRB-) (NP (NN AP)) (-RRB- -RRB-)) (PP (IN of) (NP (CD 0.68))))) (PRN (-LRB- -LRB-) (NP (CD 0.66) (SYM -) (CD 0.70)) (-RRB- -RRB-))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT a) (NN reference) (NN approach)) (, ,) (VP (VBN based) (PP (IN on) (NP (JJ logistic) (NN regression)))) (, ,)) (VP (VBD yielded) (NP (NP (NP (NN AUC)) (PP (IN of) (NP (CD 0.75) (PRN (-LRB- -LRB-) (NP (CD 0.74) (SYM -) (CD 0.77)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN AP)) (PP (IN of) (NP (CD 0.62))))) (PRN (-LRB- -LRB-) (NP (CD 0.60) (SYM -) (CD 0.64)) (-RRB- -RRB-))) (. .))
(S (NP (DT The) (JJ proposed) (NN method)) (VP (MD could) (ADVP (RB significantly)) (VP (VP (VB improve) (NP (DT the) (NN subject) (NN selection) (NN process)) (PP (IN for) (NP (NNP OA) (NML (NN drug) (HYPH -) (NN development)) (NNS trials)))) (CC and) (VP (VB help) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (VBN personalized) (JJ therapeutic) (NNS plans))))))) (. .))
